Codiak BioSciences, Inc. Investing Cash Flow
Codiak BioSciences, Inc. reported Investing Cash Flow of -$362.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2022-11-03
- Codiak BioSciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2022-09-30 was -$9.00K.
- Codiak BioSciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2022-06-30 was -$171.00K.
- Codiak BioSciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2022-03-31 was -$182.00K.
- Codiak BioSciences, Inc. net cash provided by (used in) investing activities for the quarter ending 2021-12-31 was -$332.00K.
- Codiak BioSciences, Inc. net cash provided by (used in) investing activities for fiscal 2021 was -$3.25M, a 106.24% decline from fiscal 2020.
- Codiak BioSciences, Inc. net cash provided by (used in) investing activities for fiscal 2020 was $52.01M.
- Codiak BioSciences, Inc. net cash provided by (used in) investing activities for fiscal 2019 was -$11.67M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2022-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$180.00K derived: sum of 2 quarters · filed 2022-11-03 | -$362.00K 10-Q · filed 2022-11-03 | -$694.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | -$171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$353.00K 10-Q · filed 2022-08-04 | -$685.00K derived: sum of 3 quarters · filed 2022-08-04 | -$1.23M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | -$182.00K 10-Q · filed 2022-05-05 | -$514.00K derived: sum of 2 quarters · filed 2022-05-05 | -$1.06M derived: sum of 3 quarters · filed 2022-11-03 | -$1.90M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | -$332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$880.00K derived: sum of 2 quarters · filed 2022-11-03 | -$1.72M derived: sum of 3 quarters · filed 2022-11-03 | -$3.25M 10-K · filed 2022-03-10 |
| 2021-09-30 | -$548.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$1.39M derived: sum of 2 quarters · filed 2022-11-03 | -$2.91M 10-Q · filed 2022-11-03 | -$4.08M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$839.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$2.37M 10-Q · filed 2022-08-04 | -$3.53M derived: sum of 3 quarters · filed 2022-08-04 | -$5.33M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$1.53M 10-Q · filed 2022-05-05 | -$2.69M derived: sum of 2 quarters · filed 2022-05-05 | -$4.49M derived: sum of 3 quarters · filed 2022-05-05 | -$6.01M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$2.97M derived: sum of 2 quarters · filed 2022-03-10 | -$4.49M derived: sum of 3 quarters · filed 2022-03-10 | $52.01M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$3.33M derived: sum of 2 quarters · filed 2021-11-04 | $53.17M 10-Q · filed 2021-11-04 | $46.11M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $54.98M 10-Q · filed 2021-08-05 | $47.91M derived: sum of 3 quarters · filed 2021-08-05 | |
| 2020-03-31 | $56.50M 10-Q · filed 2021-05-06 | $49.43M derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | -$7.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | -$11.67M 10-K · filed 2021-03-17 | ||
| 2019-09-30 | -$4.60M 10-Q · filed 2020-11-19 |